ESTELA NATIVIDAD PAZ ARTAL-rekin lankidetzan egindako argitalpenak (23)

2023

  1. Cell-mediated and Neutralizing Antibody Responses to the SARS-CoV-2 Omicron BA.4/BA.5-adapted Bivalent Vaccine Booster in Kidney and Liver Transplant Recipients

    Transplantation Direct, Vol. 9, Núm. 10, pp. E1536

2022

  1. Short series regarding uncontrolled donor after cardiac death: A call for caution

    Clinical Transplantation

  2. The Immunobiogram, a novel in vitro diagnostic test to measure the pharmacodynamic response to immunosuppressive therapy in kidney transplant patients

    Transplant Immunology, Vol. 75

2021

  1. Circulatory follicular helper T lymphocytes associate with lower incidence of CMV infection in kidney transplant recipients

    American Journal of Transplantation, Vol. 21, Núm. 12, pp. 3946-3957

  2. Discordance Between SARS-CoV-2-specific Cell-mediated and Antibody Responses Elicited by mRNA-1273 Vaccine in Kidney and Liver Transplant Recipients

    Transplantation Direct, Vol. 7, Núm. 12, pp. E794

2020

  1. Early Posttransplant Mobilization of Monocytic Myeloid-derived Suppressor Cell Correlates With Increase in Soluble Immunosuppressive Factors and Predicts Cancer in Kidney Recipients

    Transplantation, Vol. 104, Núm. 12, pp. 2599-2608

  2. Imbalance favoring follicular helper T cells over IL10+ regulatory B cells is detrimental for the kidney allograft

    Kidney International, Vol. 98, Núm. 3, pp. 732-743

  3. Number and function of circulatory helper innate lymphoid cells are unaffected by immunosuppressive drugs used in solid organ recipients – a single centre cohort study

    Transplant International, Vol. 33, Núm. 4, pp. 402-413

2019

  1. Longitudinal profile of circulating T follicular helper lymphocytes parallels anti-HLA sensitization in renal transplant recipients

    American Journal of Transplantation, Vol. 19, Núm. 1, pp. 89-97

2018

  1. Post-transplant hypocomplementemia: A novel marker of cardiovascular risk in kidney transplant recipients?

    Atherosclerosis, Vol. 269, pp. 204-210

2017

  1. The presence of pretransplant antiphospholipid antibodies iga anti-b-2-glycoprotein i as a predictor of graft thrombosis after renal transplantation

    Transplantation, Vol. 101, Núm. 3, pp. 597-607

2016

  1. Early renal graft function deterioration in recipients with preformed anti-MICA antibodies: Partial contribution of complement-dependent cytotoxicity

    Nephrology Dialysis Transplantation, Vol. 31, Núm. 1, pp. 150-160

  2. Isolated De Novo Antiendothelial Cell Antibodies and Kidney Transplant Rejection

    American Journal of Kidney Diseases, Vol. 68, Núm. 6, pp. 933-943

  3. Monitoring of intracellular adenosine triphosphate in CD4+ T cells to predict the occurrence of cytomegalovirus disease in kidney transplant recipients

    Transplant International, Vol. 29, Núm. 10, pp. 1094-1105

2015

  1. Association of early kidney allograft failure with preformed IgA antibodies to β2-glycoprotein I

    Journal of the American Society of Nephrology, Vol. 26, Núm. 3, pp. 735-745

  2. Potential role of post-transplant hypogammaglobulinemia in the risk of Clostridium difficile infection after kidney transplantation: a case–control study

    Infection, Vol. 43, Núm. 4, pp. 413-422

2014

  1. Assessing the risk of de novo malignancy in kidney transplant recipients: Role for monitoring of peripheral blood lymphocyte populations

    Transplantation

  2. Kinetics of peripheral blood lymphocyte subpopulations predicts the occurrence of opportunistic infection after kidney transplantation

    Transplant International, Vol. 27, Núm. 7, pp. 674-685

2013

  1. Harmful effect of preformed anti-MICA antibodies on renal allograft evolution in early posttransplantation period

    Transplantation, Vol. 96, Núm. 1, pp. 70-78

  2. Hypocomplementemia in kidney transplant recipients: Impact on the risk of infectious complications

    American Journal of Transplantation, Vol. 13, Núm. 3, pp. 685-694